Related Experiment Videos
Ace inhibitors in cardiovascular diseases
1Division of Cardiology, Central Arkansas Veteran's Healthcare System, University of Arkansas for Medical Sciences, USA.
Insights
Renin-angiotensin system blockade, including ACE inhibitors and ARBs, is crucial for managing heart failure. Evidence shows these therapies offer cardio-protective benefits, contrary to earlier beliefs.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Neuro-hormonal activation was once thought essential for survival in left ventricular dysfunction.
- This understanding has evolved significantly with new scientific evidence.
Purpose of the Study:
- To highlight the importance of renin-angiotensin blockade in contemporary heart failure management.
- To present evidence supporting the cardio-protective effects of neuro-hormonal blockade.
Main Methods:
- Review of existing scientific literature and clinical evidence.
- Analysis of studies on angiotensin-converting enzyme inhibition (ACEI) and angiotensin receptor blockade (ARB).
Main Results:
- Renin-angiotensin blockade is a cornerstone therapy for heart failure.
- Extensive evidence supports the cardioprotective roles of renin-angiotensin system (RAS) blockade and other neuro-hormonal interventions.
Conclusions:
- The role of neuro-hormonal activation in heart failure survival has been re-evaluated.
- RAS blockade demonstrates significant cardio-protective effects, improving patient outcomes.
Abstract:
Renin-angiotensin blockade is an important component of management of heart failure in the 21st century. It can be achieved by angiotensin-converting enzyme inhibition (ACEI) and angiotensin receptor blockade (ARB). Neuro-hormonal activation was considered a necessary mechanism for survival of patients with left ventricular dysfunction in 1960s and 1970s. This has been proven to be incorrect, and in fact, there is a large and growing body of evidence showing the cardio-protective effects of RAS and other neuro-hormonal blockade.